Literature DB >> 19465303

Microbial keratitis after corneal collagen crosslinking.

Juan J Pérez-Santonja1, Alberto Artola, Jaime Javaloy, Jorge L Alió, José L Abad.   

Abstract

Several infiltrates appeared in the upper midperipheral cornea of a 29-year-old woman who had had uneventful corneal collagen crosslinking (CXL) with riboflavin and ultraviolet-A light (UVA) for the treatment of keratoconus in the right eye. Staphylococcus epidermidis keratitis was confirmed by microbiological studies, which guided treatment with topical fortified antibiotic agents. Before CXL, the best spectacle-corrected visual acuity (BSCVA) in the right eye was 20/25, the manifest refraction was -0.25 -0.25 x 125, and the anterior segment was normal under biomicroscopy. Five months after the procedure, the BSCVA was 20/22, the manifest refraction was +1.00 -2.50 x 40, and slitlamp examination revealed a mild residual haze in the upper midperipheral cornea. Collagen crosslinking with riboflavin-UVA is a minimally invasive method but traditionally requires epithelial removal, which could be a predisposing factor to bacterial keratitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465303     DOI: 10.1016/j.jcrs.2009.01.036

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  39 in total

1.  Aliphatic β-nitroalcohols for therapeutic corneoscleral cross-linking: chemical stability studies using 1H-NMR spectroscopy.

Authors:  Xia Li; Yongjun Li; Mijung Kim; Stephen L Trokel; Nicholas J Turro; David C Paik
Journal:  Photochem Photobiol       Date:  2013-10-21       Impact factor: 3.421

2.  Complications of accelerated corneal collagen cross-linking: review of 2025 eyes.

Authors:  Semih Çakmak; Mehmet Emin Sucu; Yusuf Yildirim; Burcin Kepez Yildiz; Ahmet Kirgiz; Damla Leman Bektaşoğlu; Ahmet Demirok
Journal:  Int Ophthalmol       Date:  2020-07-26       Impact factor: 2.031

3.  Ultrasound-enhanced penetration of topical riboflavin into the corneal stroma.

Authors:  Ricardo Lamy; Elliot Chan; Hui Zhang; Vasant A Salgaonkar; Sam D Good; Travis C Porco; Chris J Diederich; Jay M Stewart
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

Review 4.  Corneal collagen crosslinking in keratoconus and other eye disease.

Authors:  Adel Alhayek; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

5.  Collagen cross-linking in keratoconus in Asian eyes: visual, refractive and confocal microscopy outcomes in a prospective randomized controlled trial.

Authors:  Namrata Sharma; Kunal Suri; Sri Vatsa Sehra; Jeewan S Titiyal; Rajesh Sinha; Radhika Tandon; Rasik B Vajpayee
Journal:  Int Ophthalmol       Date:  2015-02-24       Impact factor: 2.031

6.  Effect of the synthetic NC-1059 peptide on diffusion of riboflavin across an intact corneal epithelium.

Authors:  Yuntao Zhang; Pinakin Sukthankar; John M Tomich; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

Review 7.  Corneal collagen cross-linking: a review.

Authors:  David P S O'Brart
Journal:  J Optom       Date:  2014-03-20

Review 8.  Therapeutic and inducing effect of corneal crosslinking on infectious keratitis.

Authors:  Liang-Zhu Jiang; Shi-Yan Qiu; Zhi-Wei Li; Xiao Zhang; Xiang-Chen Tao; Guo-Ying Mu
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

Review 9.  Current perspectives on corneal collagen crosslinking (CXL).

Authors:  Sandeepani K Subasinghe; Kelechi C Ogbuehi; George J Dias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-06       Impact factor: 3.117

10.  Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.

Authors:  G Pron; L Ieraci; K Kaulback
Journal:  Ont Health Technol Assess Ser       Date:  2011-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.